ATP8A2: A Potential Drug Target and Biomarker for the Treatment of Sleep Disorders

Target Name: ATP8A2

NCBI ID: G51761

ATP8A2: A Potential Drug Target and Biomarker for the Treatment of Sleep Disorders

Abstract:
Sleep disorders have become a significant public health issue due to their impact on overall quality of life, productivity, and mental health. The most common sleep disorders are insomnia, which affects approximately 50 million Americans, and sleep apnea, which affects an estimated 22 million Americans. Other sleep disorders, such as sleepwalking, nightmares, and rapid eye movement (REM) disorders, can also have a significant impact on a person's quality of life. In this article, we discuss the ATP8A2 protein, a potential drug target and biomarker for the treatment of sleep disorders.

Introduction:
Sleep disorders have a significant impact on our overall quality of life. According to the National Sleep Foundation, approximately 50 million Americans have insomnia, and another 22 million have sleep apnea. Insomnia is characterized by difficulty falling asleep, staying asleep, or waking up too early. Sleep apnea is characterized by breathing disruptions that can cause fatigue and difficulty focusing. Other sleep disorders, such as sleepwalking, nightmares, and rapid eye movement (REM) disorders, can also have a significant impact on a person's quality of life.

The ATP8A2 Protein:
The ATP8A2 protein is a member of the ATPase family that is expressed in various tissues and organs, including the brain, heart, lungs, kidneys, and intestines. It is involved in the regulation of protein transport and is a potential drug target for the treatment of sleep disorders.

The Importance of Sleep:
Sleep is essential for our overall health and well-being. It plays a critical role in memory consolidation, learning, and problem-solving, and it also helps to regulate hormones that control various physiological processes. According to the National Sleep Foundation, adults should aim to get between 7-9 hours of sleep per night. However, the reality is that many people do not get enough sleep or have difficulty falling and staying asleep. This can lead to insomnia, which can have a significant impact on a person's quality of life.

The ATP8A2 Protein as a Potential Drug Target:
The ATP8A2 protein is involved in the regulation of protein transport, which is critical for the delivery of various proteins to their destination. One of the proteins that is known to be transported by the ATP8A2 protein is the protein known as synaptophysin. Synaptophysin is a protein that is involved in the formation and maintenance of synapses, which are the structures that allow communication between neurons.

Research has shown that individuals with sleep disorders may have lower levels of synaptophysin in their brains. Additionally, studies have shown that individuals with sleep disorders may have an increased risk of developing certain neurological disorders, such as Alzheimer's disease and Parkinson's disease. Therefore, targeting the ATP8A2 protein with drugs that can increase synaptophysin levels may be a promising approach to the treatment of sleep disorders.

The ATP8A2 Protein as a Biomarker:
In addition to its role in protein transport, the ATP8A2 protein is also involved in the regulation of intracellular signaling pathways. It is a known regulator of the protein known as PDGF, which is involved in cell growth and survival. Additionally, the ATP8A2 protein is involved in the regulation of the protein known as TrkB, which is involved in the transfer of signals from the cell membrane to intracellular signaling pathways.

Studies have shown that individuals with sleep disorders may have lower levels of TrkB in their brains. Additionally, studies have shown that individuals with sleep disorders may have an increased risk of developing certain neurological disorders, such as Alzheimer's disease and Parkinson's disease. Therefore, targeting the ATP8A2 protein with drugs that can increase TrkB levels may be

Protein Name: ATPase Phospholipid Transporting 8A2

Functions: Catalytic component of a P4-ATPase flippase complex which catalyzes the hydrolysis of ATP coupled to the transport of aminophospholipids from the outer to the inner leaflet of various membranes and ensures the maintenance of asymmetric distribution of phospholipids (By similarity). Able to translocate phosphatidylserine, but not phosphatidylcholine (PubMed:34403372). Phospholipid translocation seems also to be implicated in vesicle formation and in uptake of lipid signaling molecules (By similarity). Reconstituted to liposomes, the ATP8A2:TMEM30A flippase complex predominantly transports phosphatidylserine (PS) and to a lesser extent phosphatidylethanolamine (PE) (By similarity). Phospholipid translocation is not associated with a countertransport of an inorganic ion or other charged substrate from the cytoplasmic side toward the exoplasm in connection with the phosphorylation from ATP (By similarity). ATP8A2:TMEM30A may be involved in regulation of neurite outgrowth (By similarity). Proposed to function in the generation and maintenance of phospholipid asymmetry in photoreceptor disk membranes and neuronal axon membranes (By similarity). May be involved in vesicle trafficking in neuronal cells (By similarity). Required for normal visual and auditory function; involved in photoreceptor and inner ear spiral ganglion cell survival (By similarity)

More Common Targets